
Charanjit Aulakh
Examiner (ID: 11601)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1612, 1203, 1621 |
| Total Applications | 3765 |
| Issued Applications | 2855 |
| Pending Applications | 383 |
| Abandoned Applications | 582 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6918774
[patent_doc_number] => 20050096335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Heteroaryl - fused nitrogen heterocycles as therapeutic agents'
[patent_app_type] => utility
[patent_app_number] => 11/012636
[patent_app_country] => US
[patent_app_date] => 2004-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25658
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20050096335.pdf
[firstpage_image] =>[orig_patent_app_number] => 11012636
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/012636 | Heteroaryl - fused nitrogen heterocycles as therapeutic agents | Dec 14, 2004 | Abandoned |
Array
(
[id] => 5080328
[patent_doc_number] => 20070123552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-31
[patent_title] => 'Method of manufacturing of 7-ethyl-10-hydroxycamptotecin'
[patent_app_type] => utility
[patent_app_number] => 10/582650
[patent_app_country] => US
[patent_app_date] => 2004-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1558
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20070123552.pdf
[firstpage_image] =>[orig_patent_app_number] => 10582650
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/582650 | Method of manufacturing of 7-ethyl-10-hydroxycamptothecin | Dec 13, 2004 | Issued |
Array
(
[id] => 7550883
[patent_doc_number] => 08063216
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-22
[patent_title] => 'Photolabile compounds'
[patent_app_type] => utility
[patent_app_number] => 10/585013
[patent_app_country] => US
[patent_app_date] => 2004-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 24
[patent_no_of_words] => 14376
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/063/08063216.pdf
[firstpage_image] =>[orig_patent_app_number] => 10585013
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/585013 | Photolabile compounds | Dec 13, 2004 | Issued |
Array
(
[id] => 5914120
[patent_doc_number] => 20060128958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Methods for producing a hexadentate bimetallic complex'
[patent_app_type] => utility
[patent_app_number] => 11/009916
[patent_app_country] => US
[patent_app_date] => 2004-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23483
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20060128958.pdf
[firstpage_image] =>[orig_patent_app_number] => 11009916
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/009916 | Methods for producing a hexadentate bimetallic complex | Dec 9, 2004 | Issued |
Array
(
[id] => 7098545
[patent_doc_number] => 20050131004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Hydronopol derivatives as agonists on human ORL1 receptors'
[patent_app_type] => utility
[patent_app_number] => 11/007255
[patent_app_country] => US
[patent_app_date] => 2004-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25438
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20050131004.pdf
[firstpage_image] =>[orig_patent_app_number] => 11007255
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/007255 | Hydronopol derivatives as agonists on human ORL1 receptors | Dec 8, 2004 | Issued |
Array
(
[id] => 6906232
[patent_doc_number] => 20050101627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Preparation of 1H-imidazo [4,5-C] quinolin-4 amines via novel 1h-imidazo [4,5-C] quinolin-4-cyano and 1h-imidazo [4,5-C] quinolin-4-carboxamide intermediates'
[patent_app_type] => utility
[patent_app_number] => 11/009259
[patent_app_country] => US
[patent_app_date] => 2004-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3919
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20050101627.pdf
[firstpage_image] =>[orig_patent_app_number] => 11009259
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/009259 | Preparation of 1H-imidazo[4,5-C] quinolin 4-amines via novel 1H-imidazo[4,5-c] quinolin 4-cyano and 1H-imidazo[4,5-c] quinolin 4-carboxamide intermediates | Dec 8, 2004 | Issued |
Array
(
[id] => 5253952
[patent_doc_number] => 20070135408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Spiropiperidine derivatives for controlling pests'
[patent_app_type] => utility
[patent_app_number] => 10/581176
[patent_app_country] => US
[patent_app_date] => 2004-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50492
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20070135408.pdf
[firstpage_image] =>[orig_patent_app_number] => 10581176
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/581176 | Spiropiperidine derivatives for controlling pests | Dec 8, 2004 | Issued |
Array
(
[id] => 833640
[patent_doc_number] => 07396930
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-08
[patent_title] => 'Process for producing cyclic thioether and synthetic intermediate thereof'
[patent_app_type] => utility
[patent_app_number] => 11/006027
[patent_app_country] => US
[patent_app_date] => 2004-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15516
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/396/07396930.pdf
[firstpage_image] =>[orig_patent_app_number] => 11006027
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/006027 | Process for producing cyclic thioether and synthetic intermediate thereof | Dec 5, 2004 | Issued |
Array
(
[id] => 963834
[patent_doc_number] => 06949646
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-27
[patent_title] => 'Imidazonaphthyridines'
[patent_app_type] => utility
[patent_app_number] => 11/004674
[patent_app_country] => US
[patent_app_date] => 2004-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43102
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/949/06949646.pdf
[firstpage_image] =>[orig_patent_app_number] => 11004674
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/004674 | Imidazonaphthyridines | Dec 2, 2004 | Issued |
Array
(
[id] => 4496541
[patent_doc_number] => 07947703
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-24
[patent_title] => 'Phenanthridinium derivatives as DNA binding agents'
[patent_app_type] => utility
[patent_app_number] => 10/580898
[patent_app_country] => US
[patent_app_date] => 2004-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 22554
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/947/07947703.pdf
[firstpage_image] =>[orig_patent_app_number] => 10580898
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/580898 | Phenanthridinium derivatives as DNA binding agents | Nov 25, 2004 | Issued |
Array
(
[id] => 6978598
[patent_doc_number] => 20050288316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Beta-carbolines as growth hormone secretagogue receptor (GHSR) antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/995067
[patent_app_country] => US
[patent_app_date] => 2004-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47093
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20050288316.pdf
[firstpage_image] =>[orig_patent_app_number] => 10995067
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/995067 | Beta-carbolines as growth hormone secretagogue receptor (GHSR) antagonists | Nov 21, 2004 | Abandoned |
Array
(
[id] => 6958437
[patent_doc_number] => 20050214807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Environmental sensitive fluorogenic compounds and their application for singlet oxygen and protein detection'
[patent_app_type] => utility
[patent_app_number] => 10/993908
[patent_app_country] => US
[patent_app_date] => 2004-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 20026
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20050214807.pdf
[firstpage_image] =>[orig_patent_app_number] => 10993908
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/993908 | Environmental sensitive fluorogenic compounds and their application for singlet oxygen and protein detection | Nov 18, 2004 | Abandoned |
Array
(
[id] => 616492
[patent_doc_number] => 07144904
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-05
[patent_title] => 'Iron binding agents'
[patent_app_type] => utility
[patent_app_number] => 10/993417
[patent_app_country] => US
[patent_app_date] => 2004-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14161
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/144/07144904.pdf
[firstpage_image] =>[orig_patent_app_number] => 10993417
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/993417 | Iron binding agents | Nov 18, 2004 | Issued |
Array
(
[id] => 397769
[patent_doc_number] => 07294738
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-13
[patent_title] => 'Phosphorous containing steroid mimics'
[patent_app_type] => utility
[patent_app_number] => 10/992906
[patent_app_country] => US
[patent_app_date] => 2004-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7720
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/294/07294738.pdf
[firstpage_image] =>[orig_patent_app_number] => 10992906
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/992906 | Phosphorous containing steroid mimics | Nov 18, 2004 | Issued |
Array
(
[id] => 102343
[patent_doc_number] => 07728000
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-01
[patent_title] => 'Substituted quinolines for the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 10/580140
[patent_app_country] => US
[patent_app_date] => 2004-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10528
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/728/07728000.pdf
[firstpage_image] =>[orig_patent_app_number] => 10580140
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/580140 | Substituted quinolines for the treatment of cancer | Nov 17, 2004 | Issued |
Array
(
[id] => 6991394
[patent_doc_number] => 20050090431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Water soluble prodrugs of hindered alcohols'
[patent_app_type] => utility
[patent_app_number] => 10/991348
[patent_app_country] => US
[patent_app_date] => 2004-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12052
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20050090431.pdf
[firstpage_image] =>[orig_patent_app_number] => 10991348
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/991348 | Water soluble prodrugs of hindered alcohols | Nov 16, 2004 | Issued |
Array
(
[id] => 902166
[patent_doc_number] => 07335373
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-26
[patent_title] => 'Biocidal siloxane coating material containing N-halogenated amine and amide functional groups'
[patent_app_type] => utility
[patent_app_number] => 10/991358
[patent_app_country] => US
[patent_app_date] => 2004-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6746
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/335/07335373.pdf
[firstpage_image] =>[orig_patent_app_number] => 10991358
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/991358 | Biocidal siloxane coating material containing N-halogenated amine and amide functional groups | Nov 16, 2004 | Issued |
Array
(
[id] => 5237236
[patent_doc_number] => 20070129393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'Novel compounds'
[patent_app_type] => utility
[patent_app_number] => 10/579545
[patent_app_country] => US
[patent_app_date] => 2004-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17269
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20070129393.pdf
[firstpage_image] =>[orig_patent_app_number] => 10579545
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/579545 | Compounds | Nov 14, 2004 | Issued |
Array
(
[id] => 7201990
[patent_doc_number] => 20050165233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Continuous process for producing hydroxyazapirones by oxidation'
[patent_app_type] => utility
[patent_app_number] => 10/988791
[patent_app_country] => US
[patent_app_date] => 2004-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5296
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20050165233.pdf
[firstpage_image] =>[orig_patent_app_number] => 10988791
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/988791 | Continuous process for producing hydroxyazapirones by oxidation | Nov 14, 2004 | Abandoned |
Array
(
[id] => 5085939
[patent_doc_number] => 20070275990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'Heterocyclic Spiro Compound'
[patent_app_type] => utility
[patent_app_number] => 10/579271
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35159
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20070275990.pdf
[firstpage_image] =>[orig_patent_app_number] => 10579271
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/579271 | Heterocyclic Spiro Compound | Nov 11, 2004 | Abandoned |